Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Katherine Peters

Neuro Oncology · Duke University

View

Dr. Soma Sengupta

Neuro Oncology · Tufts

View

Dr. Alissa Thomas

Neuro Oncology · UVM

View

Dr. Akanksha Sharma

Neuro Oncology · Sutter Health

View

Dr. Jonathan Rosand

Neurocritical Care · Broad Institute

View

Dr. Jinsy Andrews

ALS · NYU Langone

View

Dr. Maisha Robinson

Hospice & Palliative Care · Mayo Clinic Florida

View

Dr. Michael Kentris

Epilepsy · St. Elizabeth Medical Center

View

Dr. Daniel Correa

Epilepsy · AECOM

View

Dr. Aaron Berkowitz

General Neurology · UCSF

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RMDr. Rajiv Magge
    Leading Voice

    Dr. Rajiv Magge

    Neurology · Neuro Oncology
    NewYork–Presbyterian Hospital
    drrajivmagge
    New York, NY

    Research

    Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors

    2025

    Via The Journal of Clinical Endocrinology & Metabolism

    Research

    Therapeutic manipulation and bypass of the blood-brain barrier: powerful tools in glioma treatment

    2025

    Via Neuro-Oncology Advances

    Research

    Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors

    2025

    Via Journal of Clinical Endocrinology & Metabolism

    Research

    Dual-[FMISO +FLT] PET/CT and MRI imaging in glioblastoma

    2025

    Via Medical Physics

    Research

    [Ga68] DOTATATE PET/MRI-guided radiosurgical treatment planning and response assessment in meningiomas

    2024

    Via Neuro-Oncology

    Jun 7, 2024Journal Article

    DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.

    ​
    ​

    Written by 2 Roon authors & 17 others

    Via The American Journal of Neuroradiology

    Research

    [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases

    2024

    Via European Journal of Radiology

    Research

    Concurrent immunotherapy and re-irradiation utilizing stereotactic body radiotherapy for recurrent high-grade gliomas

    2023

    Via Cancer Reports

    Research

    The treatment of aggressive prolactinomas with everolimus

    2023

    Via Pituitary

    Research

    PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes

    2022

    Via Frontiers in Oncology

    Research

    Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience

    2022

    Via Journal of Immunotherapy

    Research

    Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [Ga]-DOTATATE PET/MRI analysis in patients with meningioma

    2022

    Via Scientific Reports

    Research

    Foundations of the Diagnosis and Management of Low-Grade Gliomas

    2022

    Via World Neurosurgery

    Research

    A multidisciplinary management algorithm for brain metastases

    2022

    Via Neuro-Oncology Advances

    Research

    [68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases

    2021

    Via Journal of Neurosurgery Case Lessons